DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Bokemeyer C, Bondarenko I, Hartmann JT. et al.
Overall survival of patients with KRAS wild-type tumors treated with FOLFOX4 ± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study.
Eur J Cancer 2009; 7 (Suppl): 345 (Abstract: 6079)-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.